ISOFLOW

ISOFLOW is a vendor blend containing KPV (10mg) + TB-500 (10mg) + BPC-157 (10mg) for 30mg total. It can be understood as KLOW without GHK-Cu — swapping the collagen/matrix focus of GHK-Cu for a more targeted anti-inflammatory approach. The three-component stack combines KPV's direct NF-κB inhibition with TB-500's actin-mediated cell migration and BPC-157's broad repair signaling. ISOFLOW is marketed toward gut inflammation, systemic anti-inflammatory research, and conditions where the skin and collagen focus of GHK-Cu is less relevant. The smaller total volume (30mg vs. 80mg) may also make reconstitution more practical for some protocols.